Macelignan


CAS No. : 107534-93-0

Macelignan,107534-93-0
Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000346
Molecular Formula:C20H24O4
Molecular Weight:328.4
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

refresh
Appearance: Powder
Purity: 98.5%
Cat No:I000346
Cas No:107534-93-0
Product-Name:Macelignan

Macelignan(Anwuligan) is a natural compound isolated from Myristica fragrans Houtt; possesses therapeutic potentials against neurodegenerative diseases with oxidative stress and neuroinflammation.
IC50 value:
Target:
in vitro: Macelignan significantly attenuated the ROS production and neurotoxicity induced by glutamate in HT22 cell [1]. At 24 h of biofilm growth, S. mutans, A. viscosus and S. sanguis biofilms were reduced by up to 30%, 30% and 38%, respectively, after treatment with 10 microg/mL macelignan for 5 min [2]. Cisplatin-induced phosphorylation of c-Jun N-terminal kinase1/2 (JNK1/2) and extracellular signal-regulated kinase1/2 (ERK1/2) was abrogated by pretreatment with macelignan, however, that of p38 was not significantly affected [3].
in vivo: Macelignan attenuated the expression of phosphorylated c-Jun in cisplatin-treated mice [3]. Daily administration of macelignan reduced the spatial memory impairments induced by the chronic LPS infusions [4].


[1]. Jin DQ, et al. Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells. Biochem Biophys Res Commun. 2005 Jun 17;331(4):1264-9.
[2]. Yanti, et al. In vitro anti-biofilm activity of macelignan isolated from Myristica fragrans Houtt. against oral primary colonizer bacteria. Phytother Res. 2008 Mar;22(3):308-12.
[3]. Sohn JH, et al. Protective Effects of macelignan on cisplatin-induced hepatotoxicity is associated with JNK activation. Biol Pharm Bull. 2008 Feb;31(2):273-7.
[4]. Cui CA, et al. Macelignan attenuates LPS-induced inflammation and reduces LPS-induced spatial learning impairments in rats. Neurosci Lett. 2008 Dec 19;448(1):110-4.

Recommended Products
  • CAS No. :111223-95-1
    Product Name:

    (5Z)-3-(4-chlorophenyl)-5-[(3-nitrophenyl)methylidene]imidazolidine-2, 4-dione

    Cat No: M018604 View details
  • CAS No. :118496-37-0
    Product Name:

    2-Naphthalenecarboxamide, 4,4/'-[(9-oxo-9H-fluorene- 2,7-diyl)bis[azo(2-methyl-4,1-phenylene)azo]]bi

    Cat No: M018605 View details
  • CAS No. :120877-65-8
    Product Name:

    Pyridine, 3-(2-isocyanatoethyl)- (9CI)

    Cat No: M018606 View details
  • CAS No. :117332-69-1
    Product Name:

    14B-(P-CHLOROCINNAMOYLAMINO)-7,8-DIHYDRO-N-CYCLOPROPYLMETHYLMORPHINONE MESYLATE

    Cat No: M018610 View details